News
Upsher-Smith launches new prenatal vitamin
Upsher-Smith Laboratories has launched B-Nexa, a prescription prenatal vitamin for pregnant women who suffer from nausea and vomiting of pregnancy (NVP). B-Nexa is designed with B vitamins and ginger to help calm NVP, also...
News
Merck will pay a maximum of $37 million to settle all claims against its painkiller Vioxx in Canada.
The settlement includes $10 million in costs and fees, and will total between $21.8 million and $37 million, depending upon the number of eligible claims. The plaintiffs’ lawyer Mike Peerless said up to 2,000 Canadians...
News
BTG receives US Voraxaze approval
UK-based pharmaceutical company BTG has received US Food and Drug Adminsitration (FDA) approval for its Voraxaze medication, which is used to treat patients suffering from toxic levels of methotrexate due to kidney failure. The basis of the approval...
News
AstraZeneca and Bristol-Myers Squibb diabetes drug rejected by FDA
Approval for AstraZeneca and Bristol-Myers Squibb's diabetes drug dapagliflozin has been rejected by the US Food and Drug Administration. The FDA issued the rejection in its complete response letter, stating that additional clinical data...
News
Antidepressants cause three times more falls in people with dementia
Elderly people with dementia are three times more likely to have an injurious fall if they take antidepressants, according to research published in the British Journal of Clinical Pharmacology. The association with falls can...
News
Totally drug-resistant TB found in Mumbai
A strain of tuberculosis said to be resistant to all antibiotics has been reported in India. A study released in December by Clinical Infectious Diseases documented four cases of the disease in the country,...
News
FDA calls for strictest warning on drug linked to brain infection
The US Food and Drug Administration plans to strengthen the warning label on lymphoma drug Adcetris over concerns that it may be linked to a rare, but deadly brain infection. At the time of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















